Trial Profile
Pharmacokinetics and pharmacodynamics of edivoxetine and atomoxetine in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary) ; Edivoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 29 Dec 2015 New trial record